Novel Disease-Specific Panel of Salivary microRNAs for the Detection of Oral Squamous Cell Carcinoma from Early Invasion to Stage IV Disease
Authors:
- Iphigenia GintoniIGIphigenia Gintoni
- Stavros VassiliouSVStavros Vassiliou
- Myrto Kardara BellouMBMyrto Kardara Bellou
- Athanasios BalakasABAthanasios Balakas
- Nikolaos LefantzisNLNikolaos Lefantzis
- Veronica PapakostaVeronica Papakosta
- Dimitrios VlachakisDimitrios Vlachakis
- George P. ChrousosGeorge P. Chrousos
- Christos YapijakisCYChristos Yapijakis
Open Access
- 5 June 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 5138
Abstract
Oral squamous cell carcinoma (OSCC) is characterized by consistently high mortality rates (≤60%) despite therapeutic advances. This is attributable to diagnostic delays arising from the asymptomatic early stages and time-consuming protocols. Hence, the establishment of reliable biomarkers for the routine assessment of the oral mucosa is imperative. MicroRNAs (miRNAs), key epigenetic regulators of gene expression, represent ideal candidates given their characteristic dysregulation across different pathologies. Here, we aimed to identify novel OSCC-specific miRNAs for the saliva-based detection of OSCC from the presymptomatic stage of early invasion. Through a multistep bioinformatic workflow, four miRNAs (miR-20b-5p, miR-484, miR-185-5p and miR-181d-5p) were identified as disease-specific since they simultaneously regulated >65% of a panel encompassing the 15 primarily overexpressed oncogenes in OSCC and a stage-specific panel including the six upregulated genes that genetically define the malignant stages of sequential oral carcinogenesis. The salivary expression of the identified miRNAs was studied in 31 OSCC patients and 31 healthy controls, using quantitative real-time PCR, followed by statistical analysis and an evaluation of the diagnostic accuracy. All studied miRNAs were significantly downregulated in the saliva of OSCC patients compared to controls (miR-484, p < 0.001; miR-181d-5p, p < 0.001; miR-185, p = 0.008; miR-20b, p = 0.026) and exhibited combinatory diagnostic performance of 95.4% (p < 0.001) for OSCC detection. Their expression remained uninfluenced by lifestyle and clinicopathological parameters, including smoking/alcohol, tumor site, grade and disease stage. The proposed 4-miRNA panel exhibits high diagnostic performance for the early, saliva-based detection of OSCC, irrespective of histopathological and lifestyle confounders, highlighting its potential as a robust non-invasive screening tool.Keywords
This publication has 61 references indexed in Scilit:
- miR-185 in salivary extracellular vesicles for early diagnosis of malignant transformation in oral leukoplakia: a clinical studyClinical and Translational Oncology, 2026
- Saliva-based molecular diagnostics in oral squamous cell carcinoma (OSCC): a non-invasive frontier in oncologyEuropean Archives of Oto-Rhino-Laryngology, 2025
- Roles of miR ‐181 Family Members in OSCC : Implications for Therapy and DiagnosticsCancer Medicine, 2025
- WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targetsDiscover Oncology, 2025
- Assessing the 53‐Year Epidemiological Trends of Oral Squamous Cell Carcinoma (OSCC) in Northeastern IranClinical and Experimental Dental Research, 2025
- Epidemiology and incidence of oral squamous cell carcinoma in the Iraqi population over 5 years (2014–2018)Health Science Reports, 2023
- Ultrasensitive detection of tumor‐specific mutations in saliva of patients with oral cavity squamous cell carcinomaCancer, 2020
- Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: Retrospective study of 154 cases over 7 years in QatarAnnals of Medicine & Surgery, 2020
- The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancerMolecular Biology Reports, 2018
- Update of molecular pathobiology in oral cancer: a reviewInternational Journal of Clinical Oncology, 2014